Abstract:Soil-transmitted helminths are parasitic nematodes that inhabit the human intestine. These parasites, which include two hookworm species, Ancylostoma duodenale and Necator americanus, the whipworm Trichuris trichiura , and the large roundworm Ascaris lumbricoides , infect upwards of two billion people and are a major cause of disease burden in children and pregnant women. The challenge with treating these diseases is that poverty, safety, and inefficient public health policy have marginalized drug development and distribution to control infection in humans. Anthelmintics (anti-worm drugs) have historically been developed and tested for treatment of non-human parasitic nematodes that infect livestock and companion animals. Here we systematically compare the in vitro efficacy of all major anthelmintic classes currently used in human therapy (benzimidazoles, nicotinic acetylcholine receptor agonists, macrocyclic lactones, nitazoxanide) against species closely related to human parasitic nematodes-Ancylostoma ceylanicum, Trichuris muris , and Ascaris suum --- as well as a rodent parasitic nematode used in veterinary drug discovery, Heligmosomoides bakeri , and the free-living nematode Caenorhabditis elegans. Extensive in vitro data is complemented with single-dose in vivo data in three rodent models of parasitic diseases. We find that the effects of the drugs in vitro and in vivo can vary greatly among these nematode species, e.g., the efficacy of albendazole is strong on A. ceylanicum but weak on H . bakeri . Nonetheless, certain commonalities of the in vitro effects of the drugs can be seen, e.g., nitazoxanide consistently shows an all-or-nothing response. Our in vitro data suggest that further optimization of the clinical efficacy of some of these anthelmintics could be achieved by altering the treatment routine and/or dosing. Most importantly, our in vitro and in vivo data indicate that the hookworm A. ceylanicum is a particularly sensitive and useful model for anthelmintic studies and should be incorporated early on in drug screens for broad-spectrum human soil-transmitted helminth therapies.

Advances in research of anti-parasitic infections by berberine and its derivatives

An Extensive Comparison of the Effect of Anthelmintic Classes on Diverse Nematodes

Antimicrobial compounds of berberines:research advances

Artemisinin and its derivatives in treating protozoan infections beyond malaria

Recent research progress on small molecule compounds and its derivatives of antiparasitic drugs

Artemisinin and Its Derivatives in Treating Helminthic Infections Beyond Schistosomiasis

Design, synthesis, and biological evaluation of novel berberine derivatives against phytopathogenic fungi

Promising Antiparasitic Natural and Synthetic Products from Marine Invertebrates and Microorganisms

Advances in Research on Activities of Berberine Derivatives

Research Progress on Antiprotozoal Activity of Halofuginone

Current development and structure-activity relationship study of berberine derivatives

The novel applications and pharmological advances of berberine

Current Development and Structure–activity Relationships Research of Berberine Derivatives

Recent Research Advances in Anti-Tumor Effects of Berberine and Its Derivatives

Development and Application of Anthelminthic Drugs in China.

Development and application of anthelminthic drugs in China

Progress in Synthesis and Physiological Activity of Berberine Derivatives

The status of and trends in the pharmacology of berberine: a bibliometric review [1985–2018]

Current situation and developmental trend of anthelmintics by bibliometrics]

Research Progress on Action Mechanism of Animal Anti-parasitical Drugs

Pharmacological effects of berberine and its derivatives: a patent update